UBS Group’s AXIOS Sustainable Growth Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 AXAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,548
Closed 11502
2022
Q3
$0 Hold
1,548
﹤0.01% 11412
2022
Q2
$0 Buy
+1,548
New +$166 ﹤0.01% 11394

Other funds holding AXAC.WS

UBS Group's AXAC.WS Position: Q4 2022 in Review

UBS Group sold out of AXIOS Sustainable Growth Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (AXAC.WS) in Q4 2022, closing a stake of 1,548 shares.

UBS Group first reported a position in AXAC.WS in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 34 funds tracked by Wall St. Rank hold AXAC.WS as of Q4 2022.

  • UBS Group reported no remaining AXIOS Sustainable Growth Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 1,548 AXIOS Sustainable Growth Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022.
  • UBS Group first reported a position in AXIOS Sustainable Growth Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2022 and held it in 2 quarters.
  • UBS Group's AXIOS Sustainable Growth Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $0 in Q3 2022.
  • 34 funds tracked by Wall St. Rank held AXIOS Sustainable Growth Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.